Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.
Haematologica. 2023 Oct 1;108(10):2616-2625. doi: 10.3324/haematol.2023.282681.
Haematologica. 2023.
PMID: 37051756
Free PMC article.
Clinical Trial.
Cite
Cite